NDV-HXP-S
NDV-HXP-S is a COVID-19 vaccine candidate developed by the Government Pharmaceutical Organization (GPO) of Thailand. It is a protein subunit vaccine that uses a new technology involving the Newcastle Disease Virus (NDV) and the HexaPro (HXP) spike protein of the SARS-CoV-2 virus.
Development and Technology[edit]
The NDV-HXP-S vaccine uses a unique technology that combines the Newcastle Disease Virus (NDV) and the HexaPro (HXP) spike protein of the SARS-CoV-2 virus. The NDV is used as a vector to deliver the HXP spike protein into the body. This spike protein then triggers an immune response against the SARS-CoV-2 virus.
The vaccine is being developed by the Government Pharmaceutical Organization (GPO) of Thailand. The GPO is a state enterprise under the Ministry of Public Health that is responsible for the production and distribution of pharmaceutical products in Thailand.
Clinical Trials[edit]
The NDV-HXP-S vaccine has undergone several phases of clinical trials. The results of these trials have shown that the vaccine is safe and effective in preventing COVID-19. The vaccine has also been found to be effective against several variants of the SARS-CoV-2 virus.
Availability and Distribution[edit]
The NDV-HXP-S vaccine is currently available in Thailand. The GPO has plans to distribute the vaccine to other countries in the future.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
NDV-HXP-S -
NDV-HXP-S
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
